MARC Record from Library of Congress

LEADER: 03416cam a2200541 a 4500
001 2010455559
003 DLC
005 20120613130224.0
008 100719s2009 maua b 100 0 eng
010 $a 2010455559
015 $aGBA9B0619$2bnb
016 7 $a101521315$2DNLM
016 7 $a015417721$2Uk
020 $a9781573317580 (pbk.)
020 $a1573317586
035 $a(OCoLC)ocn455199907
040 $aNLM$cNLM$dYDXCP$dSYB$dUMC$dCUX$dIXA$dUKM$dRRR$dAGL$dCHVBK$dGEBAY$dDLC
042 $anlmcopyc$alccopycat
060 00 $aW1$bAN626YL v.1175 2009
060 10 $aQU 57$bO46o 2009
070 0 $aRM666.N87$bO45 2008
082 04 $a615.31$222
050 00 $aRM666.N87$bO448 2008
110 2 $aOligonucleotide Therapeutics Society.$bMeeting$n(4th :$d2008 :$cHarvard Medical School)
245 10 $aOligonucleotide therapeutics :$bfourth annual meeting /$cedited by John J. Rossi, Michael J. Gait, and Fritz Eckstein.
246 3 $aOligonucleotide therapeutics :$b4th annual meeting
260 $aBoston, Mass. :$bPublished by Blackwell Pub. on behalf of the New York Academy of Sciences,$c2009.
300 $avi, 92 p. :$bill. ;$c26 cm.
490 0 $aAnnals of the New York Academy of Sciences,$x0077-8923 ;$vv. 1175
500 $a"The 2008 annual conference of the Oligonucleotide Therapeutics Society took place on October 15-18 at Harvard Medical School in Boston, sponsored by the New York Academy of Sciences"--Pref.
504 $aIncludes bibliographical references.
505 00 $tToward a durable anti-HIV gene therapy based on RNA interference --$tRNA interference inhibitors of hepatitis B virus --$tAllele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA --$tLigand-targeted delivery of small interfering RNAs to malignant cells and tissues --$tStimulation of the immune system by therapeutic antisense oligodeoxynucleotides and small interfering RNAs via nucleic acid receptors : how to avoid immune activation --$tPeptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy --$tAntidote-controlled antithrombotic therapy targeting factor IXa and von Willebrand factor --$tDevelopment of antisense-mediated exon skipping as a treatment for Duchenne muscular dystrophy --$tTherapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides --$tAdditional short paper --$tOligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.
650 0 $aAntisense RNA$xTherapeutic use$vCongresses.
650 0 $aOligonucleotides$xTherapeutic use$vCongresses.
650 12 $aOligonucleotides$xtherapeutic use$vCongresses.
650 22 $aOligonucleotides$xpharmacokinetics$vCongresses.
650 22 $aOligonucleotides, Antisense$xtherapeutic use$vCongresses.
650 22 $aRNA, Small Interfering$xtherapeutic use$vCongresses.
650 7 $aOligonucleotide.$2idszbz
650 7 $aArzneimittel.$2idszbz
650 7 $aAntisense-Nukleinsäuren.$2idszbz
650 07 $aOligonucleotide$2swd
650 07 $aHeilmittel$2swd
700 1 $aRossi, John J.
700 1 $aGait, M. J.$q(Michael J.)
700 1 $aEckstein, Fritz,$d1932-
710 2 $aNew York Academy of Sciences.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy1013/2010455559-d.html